Status:
NOT_YET_RECRUITING
Preemptive TIPS for Gastric Variceal Bleeding in Patients With Cirrhosis
Lead Sponsor:
West China Hospital
Collaborating Sponsors:
Beijing YouAn Hospital
Renmin Hospital of Wuhan University
Conditions:
Portal Hypertension
Gastric Varices Bleeding
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The prevalence of gastric varices is approximately 20%. It is important to note that gastric varices tend to bleed more severely, have a higher morbidity and mortality rate, and have a 35% to 90% risk...
Eligibility Criteria
Inclusion
- Cirrhosis (diagnosed by imaging, laboratory tests, clinical symptoms, or liver biopsy);
- Admission due to acute bleeding from gastric varices (IGV1 or GOV2).
Exclusion
- Prior treatment with TIPS or surgical shunt;
- Presence of contraindications to endoscopic treatment, carvedilol, or TIPS;
- Presence of hepatocellular carcinoma exceeding Milan criteria;
- Presence of other systemic malignant tumors with expected survival time not exceeding 6 months;
- Presence of uncontrollable infection or sepsis;
- Presence of cardiac, pulmonary, or renal failure;
- Pregnant or lactating women;
- Refusal to sign the informed consent form.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT06122792
Start Date
January 1 2024
End Date
December 1 2026
Last Update
November 8 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.